Company Filing History:
Years Active: 2016
Title: Innovations in Influenza Vaccines by Masaro Kanekiyo
Introduction
Masaro Kanekiyo is a prominent inventor based in Silver Spring, MD, known for his significant contributions to the field of vaccine development. His work primarily focuses on creating novel vaccines that elicit broadly neutralizing anti-influenza antibodies. With one patent to his name, Kanekiyo's innovations are paving the way for more effective influenza prevention strategies.
Latest Patents
Kanekiyo's patent involves influenza hemagglutinin protein-based vaccines. These innovative vaccines utilize nanoparticles that display hemagglutinin trimers from the influenza virus on their surface. The nanoparticles consist of fusion proteins that include a monomeric subunit of ferritin linked to portions of the influenza hemagglutinin protein. This design allows for the self-assembly of hemagglutinin-displaying nanoparticles. Some vaccines focus solely on the stem region of the hemagglutinin protein, joined to a trimerization domain. These vaccines are designed to protect individuals against infections from heterologous influenza viruses and those that are antigenically divergent from the original virus.
Career Highlights
Kanekiyo is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this esteemed institution allows him to contribute to groundbreaking research in vaccine development and public health.
Collaborations
Throughout his career, Kanekiyo has collaborated with notable colleagues, including Gary J. Nabel and Chih-Jen Wei. These partnerships have further enhanced the impact of his research and innovations in the field of immunology.
Conclusion
Masaro Kanekiyo's work in developing influenza hemagglutinin protein-based vaccines represents a significant advancement in the fight against influenza. His innovative approach and dedication to research continue to influence the field of vaccine development.